The long-standing debate surrounding the safety of retinyl palmitate in sunscreens, particularly claims linking it to increased skin cancer risk, has once again come to the forefront following a widely circulated video by toxicologist Dr. Yvonne Burkart. These assertions, frequently echoed by "clean beauty" advocacy groups like the Environmental Working Group (EWG) in their annual sunscreen guides, suggest that this vitamin A derivative, when exposed to sunlight, can become unstable, generate free radicals, and potentially accelerate skin aging and tumor formation. However, a detailed scientific rebuttal, collaboratively produced by cosmetic chemist Michelle Wong of Lab Muffin Beauty Science and toxicologist Mohammed Kanadil of MoSkinLab, and rigorously peer-reviewed by two experienced toxicologists, Dr. Norbert Kaminski and Dr. Lyle Burgoon, unequivocally concludes that such claims are not supported by comprehensive scientific evidence and official safety assessments.
The Genesis of the Controversy: Misinformation in the "Clean Beauty" Sphere
The narrative questioning the safety of retinyl palmitate in sunscreens is not new. It has been a recurrent theme promoted by various clean beauty organizations for years, often surfacing prominently in consumer-facing reports and product ratings. These groups frequently highlight in vitro (test tube) and animal studies, presenting their findings in a manner that suggests a direct and alarming risk to human health. The Environmental Working Group (EWG), for instance, has consistently listed retinyl palmitate as a problematic ingredient in its popular annual sunscreen guides, contributing significantly to public apprehension.
More recently, this concern gained renewed traction with a video titled "You’ve been lied to about sunscreen: Toxicologist reveals 6 things you should know about sunscreen" by Dr. Yvonne Burkart. In this video, the claim regarding retinyl palmitate’s alleged photocarcinogenic properties was presented as a primary concern, emphasizing that it could contradict the fundamental purpose of sunscreen by promoting skin cancer. Dr. Burkart specifically stated that retinyl palmitate, a synthetic form of vitamin A often added for its anti-aging benefits, becomes "highly unstable" when exposed to sunlight, breaking down into "extremely reactive" free radicals. These free radicals, she posited, damage DNA and lipids, accelerate skin aging, and "may even increase the risk of tumor formation over time," citing studies that show the generation of reactive oxygen species (ROS) and lipid peroxides—known drivers of oxidative stress and photocarcinogenesis.
The rapid dissemination of such content through digital platforms underscores a critical challenge in public health communication: distinguishing between preliminary scientific findings and established regulatory conclusions. The original article by Michelle Wong, published on Lab Muffin Beauty Science on August 9, 2025, and accessed on April 16, 2026, serves as a direct, evidence-based counter-narrative to these prevailing fears.
The Scientific Rebuttal: A Collaborative and Peer-Reviewed Effort
In response to the escalating concerns and the specific claims made by Dr. Burkart, Michelle Wong, a prominent science communicator in the beauty industry, partnered with Mohammed Kanadil, a toxicologist and cosmetic safety assessor. Their collaboration, featured on both Lab Muffin Beauty Science and MoSkinLab’s platforms, aimed to provide a comprehensive, fact-based analysis of the evidence surrounding retinyl palmitate. What sets their response apart is the additional layer of scrutiny: their work was reviewed by two highly respected toxicologists, Dr. Norbert Kaminski and Dr. Lyle Burgoon, lending a significant level of academic rigor akin to formal peer review. This collective effort highlights the importance of expert consensus and thorough scientific assessment in addressing complex public health questions.
The core of their argument revolves around contextualizing the studies often cited by critics and emphasizing the conclusions of authoritative regulatory bodies. They meticulously dissect the types of evidence presented, ranging from in vitro experiments to animal studies, and explain why these isolated findings do not translate into a definitive risk for human use in sunscreens.
Deconstructing the Evidence: Misinterpretations of Early Studies
The claims against retinyl palmitate primarily lean on three types of scientific investigations:
-
In Vitro Experiments: Early studies, such as one published in 2005 by Tolleson et al., demonstrated that retinyl palmitate, when isolated in test tubes and exposed to UV radiation, can indeed break down and form reactive oxygen species (ROS). ROS are known to induce oxidative stress, which can damage cellular components, including DNA, and contribute to the initiation of various diseases, including cancer. However, the critical flaw in extrapolating these findings directly to human skin is the vastly different environment. Human skin is an incredibly complex organ, replete with an intricate network of endogenous antioxidants (like vitamin C, vitamin E, glutathione, and various enzymes) and other protective mechanisms. In this rich biological milieu, retinyl palmitate, which itself possesses antioxidant properties, is likely to behave very differently, potentially even contributing to the overall antioxidant defense rather than solely promoting oxidative damage. The simplistic conditions of a test tube cannot replicate the dynamic biochemical processes occurring in living tissue.
-
Cell Studies: Another study, published by Mei et al. in 2005, found that cells in petri dishes, when exposed to UV radiation and retinyl palmitate, exhibited an increased mutation rate. While cellular mutations are a precursor to cancer, the leap from isolated cells in a dish to a living human organism is substantial. Cell culture models lack the sophisticated protective barriers, metabolic pathways, and DNA repair mechanisms present in human skin. Furthermore, the concentrations of retinyl palmitate and the intensity of UV exposure in such experiments are often far higher than what skin would encounter under normal use conditions, making the findings less relevant for real-world risk assessment.
-
Animal Studies: The NTP Mouse Study: The most frequently cited piece of evidence against retinyl palmitate is a study conducted by the National Toxicology Program (NTP), published in 2012 (though the research was conducted earlier). Dr. Burkart specifically references this study, stating that "mice whose skin was treated with retinyl palmitate and exposed to sunlight (simulated sunlight) developed significantly more skin tumors than those animals who were not exposed to the same ingredient." This finding, at face value, appears highly concerning.
However, the context and methodology of the NTP study are crucial for accurate interpretation. The study utilized SKH-1 hairless mice, a strain specifically bred for its extreme sensitivity to UV radiation and its propensity to develop skin tumors rapidly. These mice are purposefully selected for carcinogenesis studies because they yield clear results in a shorter timeframe due to their compromised skin barrier, lack of melanin, and heightened susceptibility to UV-induced damage. Their physiological response to UV is fundamentally different from that of human skin, which has evolved sophisticated defenses against sun exposure, including melanin production and efficient DNA repair systems. Therefore, direct extrapolation of tumor rates from these highly sensitive animal models to humans is scientifically unsound without further human-relevant data.Moreover, the NTP mouse study itself presented confounding results. Intriguingly, in some experimental arms, higher UV exposure actually led to fewer tumors, an outcome difficult to reconcile with a simple photocarcinogenic effect of retinyl palmitate. Additionally, the control cream without retinyl palmitate also led to an increase in tumors compared to untreated skin. This anomaly was later attributed by safety assessors to diisopropyl adipate, an ingredient in the cream’s base, which appeared to enhance UV sensitivity in hairless mice. Crucially, subsequent testing of diisopropyl adipate on human skin did not reveal a similar effect, further underscoring the limitations of the mouse model for human risk assessment.
The Regulatory Perspective: Comprehensive Safety Assessments by the SCCS
The continued presence of retinyl palmitate in sunscreens, despite the long-standing public availability of these early studies, is not an oversight. It is a testament to the rigorous evaluation processes undertaken by authoritative regulatory bodies. The European Union’s Scientific Committee on Consumer Safety (SCCS), an independent panel of highly experienced scientists, predominantly toxicologists, is responsible for assessing the safety of cosmetic ingredients in the EU market. Their assessments are far more detailed and rigorous than typical peer-reviewed papers, considering the totality of scientific evidence, including the very studies cited by critics.
The SCCS has reviewed the safety of vitamin A derivatives, including retinyl palmitate, on multiple occasions. Their 2016 opinion, and a subsequent revision in 2022, explicitly addressed the concerns raised by the in vitro, cell, and animal studies. Their conclusions, based on a comprehensive understanding of toxicology and human physiology, are critical to understanding why retinyl palmitate is considered safe for use in sunscreens:
-
Complex Skin Environment: The SCCS recognized that the simple in vitro experiments do not reflect the complex biochemical environment of human skin. As noted, skin contains numerous endogenous antioxidants that can mitigate oxidative stress. In this context, retinyl palmitate is likely to act as a beneficial antioxidant, contributing to the skin’s defense against UV-induced damage, rather than solely generating free radicals.
-
Human vs. Hairless Mouse Skin: The SCCS emphasized the vast physiological differences between hairless mice and humans. Human skin is significantly more adapted to sun exposure, possessing robust protective and repair mechanisms. Therefore, the heightened sensitivity and accelerated tumor formation observed in hairless mice cannot be directly extrapolated to human risk. In humans, retinoids, when properly formulated and used, can actually be protective.
-
Real-World Data and Clinical Experience: Dermatologists have utilized various retinoids, including forms similar to retinyl palmitate (like retinol and tretinoin), for over 50 years. These compounds are not only used for anti-aging but also actively prescribed for the prevention and treatment of certain precancerous skin conditions and some forms of skin cancer. If retinoids in sunscreens or other topical applications significantly increased skin cancer risk, this long history of clinical use and extensive patient monitoring would have undoubtedly revealed such a serious adverse effect. The absence of such widespread clinical evidence strongly supports their safety profile.
-
Confounding Factors in the NTP Study: The SCCS critically evaluated the anomalies within the NTP mouse study, specifically acknowledging the potential role of diisopropyl adipate in the base formulation, which seemed to artificially enhance UV sensitivity in the mice. This nuanced understanding highlights the importance of not isolating a single ingredient’s effect from its formulation context or the specific biological model used.
Based on this comprehensive review, the SCCS consistently concluded that retinyl palmitate is safe for use in sunscreens. It is noteworthy that the 2022 SCCS report did recommend restricting the total amount of vitamin A (retinol, retinyl acetate, retinyl palmitate) in cosmetic products due to concerns about overall systemic vitamin A intake from various sources (food, supplements, and cosmetics combined). This recommendation, however, was not based on photocarcinogenicity concerns related to sunscreens but rather on the potential for exceeding safe daily intake levels, demonstrating the SCCS’s cautious and thorough approach to safety, even when concerns are unrelated to the initial claims. This distinction is crucial: the SCCS is indeed cautious, but its caution is based on robust data and systemic effects, not unsubstantiated fears of skin cancer promotion in sunscreens.
The Broader Context of Retinoids in Dermatology
Retinoids, a class of compounds derived from vitamin A, are cornerstones of dermatological treatment. Tretinoin (retinoic acid), for example, is a prescription medication widely used for acne, anti-aging, and crucially, for the prevention and treatment of actinic keratoses, which are precancerous lesions. Oral retinoids are also used to prevent skin cancer in high-risk individuals. This extensive clinical history and the known therapeutic benefits of retinoids further underscore the disconnect between the alarmist claims regarding retinyl palmitate in sunscreens and the established medical understanding of vitamin A derivatives. The idea that a common retinoid derivative, when formulated in a sunscreen, would reverse its protective potential and become a carcinogen, stands in stark contrast to decades of dermatological practice and research.
The Peril of Misinformation and the Role of Science Communication
The recurring debate around retinyl palmitate exemplifies the challenges posed by health misinformation, particularly within the "clean beauty" movement. While advocating for safer products is a laudable goal, the approach often involves cherry-picking isolated studies, misinterpreting scientific data, and creating fear-based narratives around common ingredients. This can lead to widespread public confusion and, more dangerously, impact public health.
In the case of sunscreens, unsubstantiated fears about ingredients like retinyl palmitate can deter individuals from using sunscreen altogether. Given the unequivocal scientific consensus on the importance of sunscreen in preventing skin cancer and premature aging, encouraging sunscreen avoidance due to misleading claims poses a significant public health risk. Skin cancer, including melanoma, basal cell carcinoma, and squamous cell carcinoma, remains a pervasive health concern globally, and consistent use of broad-spectrum sunscreen is a primary preventive measure.
The collaborative effort by Lab Muffin Beauty Science and MoSkinLab, with its rigorous peer review, represents a vital contribution to science communication. It demonstrates the importance of relying on comprehensive, multi-faceted scientific assessments from official regulatory bodies rather than individual studies or interpretations by non-experts. When evaluating product safety, the "red flag" should be raised not when an individual study suggests a potential issue, but when that study is presented in isolation, disregarding the broader body of evidence and the conclusions of expert panels specifically tasked with safety assessments.
Conclusion: Expert Consensus Affirms Safety
In conclusion, the scientific consensus, as reflected by the rigorous evaluations of independent expert bodies like the EU’s Scientific Committee on Consumer Safety, affirms that retinyl palmitate in sunscreens does not increase the risk of skin cancer. The claims suggesting otherwise are based on misinterpretations and oversimplifications of preliminary in vitro and animal studies, which do not accurately reflect the complex biological environment of human skin or the conditions of real-world use. Dermatologists have long utilized retinoids for their skin-protective and even cancer-preventative properties.
The comprehensive rebuttal provided by Michelle Wong and Mohammed Kanadil, supported by expert toxicologists, serves as a crucial reminder to consumers and media outlets alike: when confronted with alarming claims about cosmetic ingredient safety, it is imperative to consult authoritative scientific bodies and evidence-based science communicators who synthesize the entirety of scientific data rather than focusing on isolated findings. Prioritizing fear-based narratives over established scientific consensus can have detrimental consequences for public health, particularly by undermining the use of essential protective measures like sunscreen. The verdict remains clear: retinyl palmitate in sunscreens is safe, and its purported link to increased skin cancer risk is a myth debunked by robust scientific inquiry.
